Counting the Cost - Campaign background and references
Cost benefit analysis is used to aid decisions on vaccination policy, and has become an increasingly important factor in reaching such decisions, however accurate cost of illness data is essential for this to be reliable.
At present there is little information in the UK about the direct and indirect lifetime costs associated with treating long-term sequelae of meningococcal disease and in particular, the costs of specialist rehabilitation for people disabled by their illness.
The work here identifies costs associated with a severe cases of meningococcal disease and bacterial meningitis and provides the basis for the Counting the Cost campaign.
Counting the cost: A severe case of meningococcal septicaemia
Counting the cost: A severe case of bacterial meningitis